GCA
TMO icon

Greenwood Capital Associates’s Thermo Fisher Scientific TMO Stock Holding History

Greenwood Capital Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,111
Closed -$646K – 259
2024
Q1 		$646K Sell
1,111
-40
-3% -$22.4K 0.09% 173
2023
Q4 		$611K Sell
1,151
-13,207
-92% -$6.39M 0.08% 173
2023
Q3 		$7.27M Sell
14,358
-110
-0.8% -$58.6K 1.06% 28
2023
Q2 		$7.55M Sell
14,468
-3,582
-20% -$1.93M 1.06% 31
2023
Q1 		$10.4M Sell
18,050
-6,220
-26% -$3.51M 1.49% 13
2022
Q4 		$13.4M Sell
24,270
-518
-2% -$274K 2.19% 7
2022
Q3 		$12.6M Buy
24,788
+824
+3% +$461K 2.16% 8
2022
Q2 		$13M Buy
23,964
+3,670
+18% +$2.02M 2.08% 8
2022
Q1 		$12M Buy
20,294
+4,724
+30% +$2.71M 3.15% 9
2021
Q4 		$10.4M Sell
15,570
-215
-1% -$134K 1.47% 20
2021
Q3 		$9.02M Buy
15,785
+1,338
+9% +$734K 1.39% 22
2021
Q2 		$7.29M Buy
14,447
+958
+7% +$452K 1.1% 35
2021
Q1 		$6.16M Buy
13,489
+67
+0.5% +$32K 0.97% 35
2020
Q4 		$6.25M Sell
13,422
-208
-2% -$97.5K 1.05% 34
2020
Q3 		$6.02M Buy
13,630
+399
+3% +$165K 1.17% 30
2020
Q2 		$4.79M Buy
13,231
+40
+0.3% +$13.4K 1.09% 38
2020
Q1 		$3.74M Buy
+13,191
New +$4.16M 1.1% 40

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Greenwood Capital Associates's TMO Position: Q2 2024 in Review

Greenwood Capital Associates sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 1,111 shares — an estimated $646K sold.

Greenwood Capital Associates first reported a position in TMO in Q1 2020 and held it in 17 quarters. The position peaked at $13.4M in Q4 2022. 2,543 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Greenwood Capital Associates reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Greenwood Capital Associates sold 1,111 Thermo Fisher Scientific shares in Q2 2024, an estimated $646K.
  • Greenwood Capital Associates first reported a position in Thermo Fisher Scientific in Q1 2020 and held it in 17 quarters.
  • Greenwood Capital Associates's Thermo Fisher Scientific position peaked at $13.4M in Q4 2022.
  • 2,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Greenwood Capital Associates's 13F filing for Q2 2024, filed 8 Aug 2024.